Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$10.83
+11.76%today
MKT CAP
$576M
+20.5% · 1Y
Earnings History
-106.7%
+29.7%
-31.0%
-25.8%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$10.83
Low
$8.00
Analyst Mean
$16.77
High
$26.00
13 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-9.0x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership0.4%
Institutional Ownership62.6%
Short % of Float5.19%
Days to Cover3.3d
1 Week+16.3%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| THOMAS STEPHEN BASIL | Director | Sale | 50,000 | $7.00 | $0.35M | 2026-02-26 |
| THOMAS STEPHEN BASIL | Director | Sale | 100,000 | $5.23 | $0.53M | 2026-02-13 |
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Buy | 7,111 | $3.50 | $0.02M | 2026-01-05 |
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Buy | 314,561 | $2.18 | $0.75M | 2025-12-12 |
| THOMAS STEPHEN BASIL | Director | Stock | 100,375 | $0.00 | $0.00M | 2025-08-07 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | institution | 23.64% | $0.14B | -64.05% | 2025-12-31 |
| MPM Bioimpact LLC | institution | 5.59% | $0.03B | +100.00% | 2025-12-31 |
| Price (T.Rowe) Associates Inc | institution | 4.03% | $0.02B | +265.07% | 2025-12-31 |
| T. Rowe Price Health Sciences Fund, Inc. | fund | 3.13% | $0.02B | +281.02% | 2025-12-31 |
| Adar1 Capital Management, LLC | institution | 3.00% | $0.02B | +972.77% | 2025-12-31 |
| Vanguard Group Inc | institution | 2.81% | $0.02B | +1.88% | 2025-12-31 |
| Affinity Asset Advisors, Llc | institution | 2.72% | $0.02B | +0.00% | 2025-12-31 |
| Kynam Capital Management, LP | institution | 2.15% | $0.01B | +0.00% | 2025-12-31 |
| Great Point Partners LLC | institution | 2.05% | $0.01B | +100.00% | 2025-12-31 |
| Sphera Funds Management Ltd. | institution | 1.95% | $0.01B | +114.39% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 1.79% | $0.01B | -0.30% | 2025-12-31 |
| Point72 Asset Management, L.P. | institution | 1.50% | $0.01B | +100.00% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.58% | $0.00B | +0.00% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.29% | $0.00B | -0.36% | 2026-02-28 |
| Bridgeway Funds, Inc.-Ultra-Small Company Market Fund | fund | 0.21% | $0.00B | +0.00% | 2025-12-31 |
| T. ROWE PRICE Eqy. SERIES, INC.-T. Rowe Price Health Sciences PORT. | fund | 0.19% | $0.00B | +250.00% | 2025-12-31 |
| iShares Trust-iShares Micro-Cap ETF | fund | 0.16% | $0.00B | -6.03% | 2026-03-31 |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | fund | 0.10% | $0.00B | +100.00% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | fund | 0.10% | $0.00B | +0.00% | 2026-02-28 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | fund | 0.08% | $0.00B | +22.79% | 2026-02-28 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for CLYM.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.